Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 14 of 14 publications.

Yang J, Bogerd HP, Le S, Cullen BR. The human endogenous retrovirus K Rev response element coincides with a predicted RNA folding region. RNA. 2000 Nov;6:1551-64.

Bogerd HP, Wiegand HL, Yang J, Cullen BR. Mutational definition of functional domains within the Rev homolog encoded by human endogenous retrovirus K. J Virol. 2000 Oct;74(20):9353-61.

Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana E. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet. 2000 Jul 28;370(9584):336-41.

Njue AI, Prichard RK. Cloning a glutamate-gated chloride channel gene homologue from the cattle nematode cooperia oncophora. Poster presented at the 45th Annual Meeting of the American Association of Veterinary Parasitologists; July 2000.

Andrews CW, Bennett L, Yu LX. Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship. Pharm Res. 2000 Jun 1;17(6):639-44.

Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1108-16. doi: 10.1067/mai.2000.105711.

Wolfe J, Rooklin A, Grady J, Munk ZM, Stevens A, Prillaman B, Duke S, Harding S. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids. J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1153-61. doi: 10.1067/mai.2000.107037

Sesti A, Albright A, McLaughlin-Miley A, Copley-Merriman K. A methodology to measure productivity of health outcomes groups. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; May 2000.

Wang A, Graham L, Copley-Merriman K. Treatment satisfaction in outcomes research: an overview of study measures. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; May 2000.

Sculpher M, Palmer MK, Heyes AE. Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid. Pharmacoeconomics. 2000 Apr;17(4):361-70.

McGrath M. Issues in designing, selecting, and interpreting a quality of life instrument. Poster presented at the Outcomes Research & Design Conference; March 2000.

Shapiro G, Lumry W, Wolfe J, Given J, White MV, Woodring A, Baitinger L, House K, Prillaman B, Shah T. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):527-34. doi: 10.1164/ajrccm.161.2.9905091

Laforce C, Woodring A, Baitinger L, House K, Prillaman B, Shah T. 35 Salmeterol 50mcg/Fluticasone propionate 100mcg diskus combination product demonstrates improvements in lung function regardless of baseline corticosteroid therapy. Poster presented at the AAAAI 56th Annual Meeting; March 3, 2000. [abstract] J Allergy Clin Immunol. 2000 Jan 1; 105(1):PS12. doi: 10.1016/S0091-6749(00)90467-6

Caro JJ, Klittich WS, Raggio G, Kavanagh PL, O'Brien JA, Shomphe LA, Flegel KM, Copley-Merriman C, Sigler C. Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes. Clin Ther. 2000 Jan;22(1):116-27.